Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Decoy Therapeutics Inc (DCOY) had Return on Equity of -212.58% for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-12.52M |
|
-- |
|
-- |
|
$12.61M |
|
$-12.61M |
|
$0.10M |
|
$-12.52M |
|
$-12.52M |
|
$-12.52M |
|
$-12.52M |
|
$-12.52M |
|
$-12.52M |
|
$-12.61M |
|
$-12.61M |
|
0.10M |
|
0.10M |
|
$-129.10 |
|
$-129.10 |
|
| Balance Sheet Financials | |
$10.99M |
|
$0.04M |
|
$0.07M |
|
$11.06M |
|
$5.17M |
|
-- |
|
-- |
|
$5.17M |
|
$5.89M |
|
$5.89M |
|
$5.89M |
|
0.53M |
|
| Cash Flow Statement Financials | |
$-4.83M |
|
$0.76M |
|
$12.34M |
|
$2.43M |
|
$10.71M |
|
$8.28M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.13 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-5.40M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-212.58% |
-212.58% |
|
-113.22% |
|
-212.58% |
|
$11.07 |
|
$-55.73 |
|
$-49.78 |
|